Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Drinks containing anthocyanin-rich blackcurrant extract decrease postprandial blood glucose, insulin and incretin concentrations.

Castro-Acosta ML, Smith L, Miller RJ, McCarthy DI, Farrimond JA, Hall WL.

J Nutr Biochem. 2016 Dec;38:154-161. doi: 10.1016/j.jnutbio.2016.09.002. Epub 2016 Sep 14.

2.

Effects of Treated versus Untreated Polystyrene on Caspofungin In Vitro Activity against Candida Species.

Fothergill AW, McCarthy DI, Albataineh MT, Sanders C, McElmeel M, Wiederhold NP.

J Clin Microbiol. 2016 Mar;54(3):734-8. doi: 10.1128/JCM.02659-15. Epub 2016 Jan 13.

3.

The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.

Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI, Fukuda Y, Mitsuyama J, Patterson TF.

J Antimicrob Chemother. 2016 Mar;71(3):692-5. doi: 10.1093/jac/dkv398. Epub 2015 Nov 29.

4.

First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.

Wiederhold NP, Gil VG, Gutierrez F, Lindner JR, Albataineh MT, McCarthy DI, Sanders C, Fan H, Fothergill AW, Sutton DA.

J Clin Microbiol. 2016 Jan;54(1):168-71. doi: 10.1128/JCM.02478-15. Epub 2015 Oct 21.

5.

The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.

Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI, Kirkpatrick WR, Fukuda Y, Mitsuyama J, Patterson TF.

Antimicrob Agents Chemother. 2015 Feb;59(2):1341-3. doi: 10.1128/AAC.04228-14. Epub 2014 Dec 1.

6.

The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.

Wiederhold NP, Najvar LK, Fothergill AW, McCarthy DI, Bocanegra R, Olivo M, Kirkpatrick WR, Everson MP, Duncanson FP, Patterson TF.

Antimicrob Agents Chemother. 2015 Jan;59(1):690-2. doi: 10.1128/AAC.03944-14. Epub 2014 Oct 20.

7.

Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.

Wiederhold NP, Fothergill AW, McCarthy DI, Tavakkol A.

Antimicrob Agents Chemother. 2014 Jun;58(6):3553-5. doi: 10.1128/AAC.02706-13. Epub 2014 Apr 7.

8.

Impact of new antifungal breakpoints on antifungal resistance in Candida species.

Fothergill AW, Sutton DA, McCarthy DI, Wiederhold NP.

J Clin Microbiol. 2014 Mar;52(3):994-7. doi: 10.1128/JCM.03044-13. Epub 2014 Jan 8.

9.

Screening for drug-resistant Candida yeasts with chromogenic agar.

Kirkpatrick WR, Zimmerman JD, Haikal FP, Broker MJ, Brockway E, Fothergill AW, McCarthy DI, Patterson TF, Redding SW.

Med Mycol. 2010 Sep;48(6):807-16. doi: 10.3109/13693780903514542.

10.

Correlation of cellular changes and spatial memory during aging in rats.

Jacobson L, Zhang R, Elliffe D, Chen KF, Mathai S, McCarthy D, Waldvogel H, Guan J.

Exp Gerontol. 2008 Oct;43(10):929-38. doi: 10.1016/j.exger.2008.08.002. Epub 2008 Aug 12.

PMID:
18761081
11.

Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.

Bocanegra R, Najvar LK, Hernandez S, McCarthy DI, Graybill JR.

Antimicrob Agents Chemother. 2005 Dec;49(12):5139-41.

12.

Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.

Burn AK, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, McCarthy DI, Rinaldi MG, Redding SW.

J Clin Microbiol. 2004 Dec;42(12):5846-8.

13.

Alternatives to amphotericin B for Candida rugosa infection.

Hernandez S, Gonzalez GM, McCarthy DI, Colombo AL, Najvar LK, Bocanegera R, Graybill JR.

J Antimicrob Chemother. 2004 Aug;54(2):477-80. Epub 2004 Jun 23.

PMID:
15215225
14.
15.

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR.

Antimicrob Agents Chemother. 2002 May;46(5):1581-2.

16.

Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia.

Iwen PC, Sigler L, Tarantolo S, Sutton DA, Rinaldi MG, Lackner RP, McCarthy DI, Hinrichs SH.

J Clin Microbiol. 2000 Jan;38(1):375-81.

17.

Fluconazole disk diffusion susceptibility testing of Candida species.

Kirkpatrick WR, Turner TM, Fothergill AW, McCarthy DI, Redding SW, Rinaldi MG, Patterson TF.

J Clin Microbiol. 1998 Nov;36(11):3429-32.

18.

Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.

Kirkpatrick WR, Revankar SG, Mcatee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, Sanche SE, Cantu RA, Rinaldi MG, Patterson TF.

J Clin Microbiol. 1998 Oct;36(10):3007-12.

19.
20.

Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.

Patterson TF, Kirkpatrick WR, Revankar SG, McAtee RK, Fothergill AW, McCarthy DI, Rinaldi MG.

J Clin Microbiol. 1996 Dec;34(12):3237-9.

Supplemental Content

Loading ...
Support Center